Showing results (1341-1350 of 1,377) with videos related to
Sort By:
Pageof 138
Hepatology (Baltimore, Md.)|April 14, 2011
Racial differences in hepatitis C treatment eligibilityMichael T Melia, Andrew J Muir, Jonathan McCone, et al.BMC Genomics|September 21, 2004
PEDRo: a database for storing, searching and disseminating experimental proteomics dataKevin Garwood, Thomas McLaughlin, Chris Garwood, et al.Journal of Thrombosis and Haemostasis : JTH|October 19, 2017
The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosisB R Branchford, T J Stalker, L Law, et al.Journal of Hepatology|December 24, 2013
Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null responseJohn M Vierling, Mitchell Davis, Steven Flamm, et al.Plos One|September 28, 2020
Screening for Fabry Disease in patients with unexplained left ventricular hypertrophyChandu Sadasivan, Josie T Y Chow, Bun Sheng, et al.European Heart Journal|January 31, 2019
Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomesJacqueline Saw, Andrew Starovoytov, Karin Humphries, et al.Neurology|April 15, 2009
Boosting enrollment in neurology trials with Local Identification and Outreach Networks (LIONs)W N Kernan, C M Viscoli, D Demarco, et al.The New England Journal of Medicine|July 24, 2009
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infectionJohn G McHutchison, Eric J Lawitz, Mitchell L Shiffman, et al.Heart and Vessels|January 28, 2022
Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)Carol Anne Graham, Mary K Tan, Derek P Chew, et al.Omics : a Journal of Integrative Biology|August 12, 2006
Annotation of environmental OMICS data: application to the transcriptomics domainNorman Morrison, A Joseph Wood, David Hancock, et al.Pageof 138